2004
DOI: 10.1097/01.fpc.0000114749.08559.e4
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a novel variant CYP2C9 allele in Chinese

Abstract: This study suggests that this novel CYP2C9 allele was correlated with reduced plasma clearance of drugs that are substrates for CYP2C9.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
77
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 87 publications
(80 citation statements)
references
References 19 publications
2
77
1
Order By: Relevance
“…In our study, concentrations of 4-hydroxytolbutamide of the CYP2C9*3/*3 and CYP2C9*3/*13 subjects were lower than those of the CYP2C9*1/*1, CYP2C9*1/*3, and CYP2C9*1/*13 subjects. Si et al (2004) reported that one individual with the genotype of CYP2C9*3/*13 had a 108-hour t 1/2 of tolbutamide, which was much longer than that (t 1/2 of 56.9 hours) discovered in our study. We believe that the longer monitoring time of drug concentration in our present study makes our result more precise than the previous report.…”
Section: Discussioncontrasting
confidence: 51%
See 1 more Smart Citation
“…In our study, concentrations of 4-hydroxytolbutamide of the CYP2C9*3/*3 and CYP2C9*3/*13 subjects were lower than those of the CYP2C9*1/*1, CYP2C9*1/*3, and CYP2C9*1/*13 subjects. Si et al (2004) reported that one individual with the genotype of CYP2C9*3/*13 had a 108-hour t 1/2 of tolbutamide, which was much longer than that (t 1/2 of 56.9 hours) discovered in our study. We believe that the longer monitoring time of drug concentration in our present study makes our result more precise than the previous report.…”
Section: Discussioncontrasting
confidence: 51%
“…8, 0.11, 0.09, and 0.94, 0.04, 0.02 (Scordo et al, 2001), respectively. CYP2C9*13 was first discovered in Chinese Han population by Si et al (2004) and was reported to have a frequency of 0.02% in Chinese. Thereafter, a series of investigations into the catalytic activity of CYP2C9*13 in vivo and in vitro were subsequently performed using tolbutamide, diclofenac, and lornoxicam as the probing substrates (Guo et al, 2005a(Guo et al, , 2005b.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, there has been a report of an individual heterozygous for CYP2C9*3 and a novel CYP2C9 allele, CYP2C9*13 (L90P), in an Asian population. The latter was suggested to contribute to the PM phenotype (Si et al, 2004).…”
mentioning
confidence: 99%
“…The CYP2C9*8, *11, and *12 alleles have altered in vitro metabolic activities compared with the wild-type allele, CYP2C9*1 (10 ). Finally, CYP2C9*13 was identified in a Chinese population with an allele frequency of 0.01 and was associated with decreased CYP2C9 activity (11 ).…”
Section: Pyrosequencing Methods For Genotypingmentioning
confidence: 97%
“…A larger sample of these populations would be required to identify individuals carrying these alleles. Additionally, with the recent discovery of other CYP2C9 allelic variants (10,11 ), adaptations of this method could allow detection of these variants.…”
Section: Pyrosequencing Methods For Genotypingmentioning
confidence: 99%